cytosine has been researched along with Papilloma in 82 studies
Papilloma: A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the history of an 8-year-old girl who was treated for suspected lung lesions of respiratory papillomatosis with Indole-3-Carbinol, local and intravenous injections of Cidofovir for 27 months." | 7.73 | Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. ( Bodart, E; de Bilderling, G; De Clercq, E; Lawson, G; Naesens, L; Remacle, M; Snoeck, R; Tuerlinckx, D, 2005) |
| "Respiratory papillomatosis is a rare and often severe disease, usually localized in the larynx." | 5.30 | Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. ( De Clercq, E; Desloovere, C; Feenstra, L; Naesens, L; Snoeck, R; Van Ranst, M; Wellens, W, 1998) |
| "We report the history of an 8-year-old girl who was treated for suspected lung lesions of respiratory papillomatosis with Indole-3-Carbinol, local and intravenous injections of Cidofovir for 27 months." | 3.73 | Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. ( Bodart, E; de Bilderling, G; De Clercq, E; Lawson, G; Naesens, L; Remacle, M; Snoeck, R; Tuerlinckx, D, 2005) |
| " However, questions remain regarding the optimal dosing schedule and side-effect profile." | 2.72 | 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. ( Akst, LM; Chung, BJ; Koltai, PJ, 2006) |
| "Laryngeal papillomatosis is characterised by multiple papillomata affecting the upper respiratory tract." | 1.37 | Novel method of intralesional cidofovir injection into laryngotracheal papillomata. ( Al-Shukri, J; Moir, AA; Sahota, RS; Uddin, FJ, 2011) |
| "Respiratory papillomatosis affects the larynx in most cases." | 1.37 | Adjuvant therapy for laryngeal papillomatosis. ( Bahar, MS; Boltežar, IH; Gale, N; Matičič, M; Poljak, M; Zargi, M, 2011) |
| "Papillomas were harvested from two patients pre- and post-cidofovir treatment." | 1.35 | Cidofovir modulated gene expression in recurrent respiratory papillomatosis. ( Kerschner, JE; Patel, NJ; Poetker, DM, 2008) |
| "Recurrent laryngeal papillomatosis is caused by the human papilloma virus and characterized by multiple exophytic lesions of the vocal tract; it is a benign disease, but one that tends to recur after removal of growths." | 1.35 | Cidofovir injection for recurrent laryngeal papillomatosis. ( Lee, JC; Lin, YS; Shi, ZP; Wang, CH, 2008) |
| "Recurrent laryngeal papillomatosis is a benign disease of the larynx often leading to organic and functional restrictions." | 1.34 | Intralesional Cidofovir application in recurrent laryngeal papillomatosis. ( Bloching, M; Neumann, K; Pudszuhn, A; Welzel, C, 2007) |
| "The two other patients showed recurrences, but at a lower rate than previously." | 1.33 | Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study. ( Dikkers, FG, 2006) |
| " Complete cures were obtained using 1% (w/v) topical cidofovir at dosing schedules of twice daily for 8 weeks beginning at 4 weeks after CRPV infection, which represents a time when papillomas were clearly visible." | 1.31 | In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. ( Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD, 2000) |
| "Respiratory papillomatosis is a rare and often severe disease, usually localized in the larynx." | 1.30 | Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. ( De Clercq, E; Desloovere, C; Feenstra, L; Naesens, L; Snoeck, R; Van Ranst, M; Wellens, W, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (7.32) | 18.2507 |
| 2000's | 61 (74.39) | 29.6817 |
| 2010's | 15 (18.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orssaud, C | 1 |
| Wermert, D | 1 |
| Roux, A | 1 |
| Laccourreye, O | 1 |
| Sors, H | 1 |
| Roche, O | 1 |
| Dufier, JL | 1 |
| Ahmed, MM | 1 |
| Connor, MP | 1 |
| Palazzolo, M | 1 |
| Thompson, ME | 1 |
| Lospinoso, J | 1 |
| O'Connor, P | 1 |
| Howard, NS | 1 |
| Maturo, SC | 1 |
| Poetker, DM | 1 |
| Patel, NJ | 1 |
| Kerschner, JE | 2 |
| Capaccio, P | 1 |
| Ottaviani, F | 1 |
| Cuccarini, V | 1 |
| Corbellino, M | 1 |
| Parravicini, C | 1 |
| Menzo, S | 1 |
| Schindler, A | 1 |
| Pignataro, L | 1 |
| McMurray, JS | 1 |
| Connor, N | 1 |
| Ford, CN | 1 |
| Bielecki, I | 1 |
| Mniszek, J | 1 |
| Cofała, M | 1 |
| Derkay, C | 1 |
| Carvalho, CM | 1 |
| Huot, L | 1 |
| Charlois, AL | 1 |
| Khalfallah, SA | 1 |
| Chapuis, F | 1 |
| Froehlich, P | 5 |
| Lott, DG | 1 |
| Krakovitz, PR | 1 |
| Verguts, MM | 1 |
| Genbrugge, E | 1 |
| de Jong, FI | 1 |
| Donne, AJ | 2 |
| Hampson, L | 1 |
| He, XT | 1 |
| Day, PJ | 1 |
| Salway, F | 1 |
| Rothera, MP | 2 |
| Homer, JJ | 2 |
| Hampson, IN | 1 |
| Carney, AS | 1 |
| Evans, AS | 1 |
| Mirza, S | 1 |
| Psaltis, A | 1 |
| Preuss, SF | 1 |
| Quante, G | 1 |
| Sajan, JA | 1 |
| Merati, AL | 1 |
| Osipov, V | 1 |
| Szabo, S | 1 |
| Blumin, JH | 2 |
| Chadha, NK | 3 |
| James, A | 2 |
| Gupta, HT | 1 |
| Robinson, RA | 2 |
| Murray, RC | 1 |
| Karnell, LH | 1 |
| Smith, RJ | 3 |
| Hoffman, HT | 2 |
| Man, LX | 1 |
| Statham, MM | 1 |
| Rosen, CA | 3 |
| Donne, A | 1 |
| Rothera, M | 1 |
| Homer, J | 1 |
| Sahota, RS | 1 |
| Uddin, FJ | 1 |
| Al-Shukri, J | 1 |
| Moir, AA | 1 |
| Tjon Pian Gi, RE | 1 |
| Dietz, A | 1 |
| Djukic, V | 1 |
| Eckel, HE | 1 |
| Friedrich, G | 1 |
| Golusinski, W | 1 |
| Hantzakos, A | 1 |
| Lawson, G | 2 |
| Remacle, M | 2 |
| Rihkanen, H | 1 |
| Dikkers, FG | 3 |
| Boltežar, IH | 1 |
| Bahar, MS | 1 |
| Zargi, M | 1 |
| Gale, N | 1 |
| Matičič, M | 1 |
| Poljak, M | 1 |
| Ablanedo-Terrazas, Y | 1 |
| Soda-Merhy, A | 1 |
| Hernández-Palestina, M | 1 |
| Ormsby, CE | 1 |
| Reyes-Terán, G | 1 |
| Cavel, O | 1 |
| Ayari, S | 3 |
| Coulombeau, B | 3 |
| Bielamowicz, S | 1 |
| Villagomez, V | 1 |
| Stager, SV | 1 |
| Wilson, WR | 2 |
| El Hakim, H | 1 |
| Waddell, AN | 1 |
| Crysdale, WS | 1 |
| Milczuk, HA | 1 |
| Akst, LM | 2 |
| Lee, W | 1 |
| Discolo, C | 1 |
| Knott, D | 1 |
| Younes, A | 1 |
| Koltai, PJ | 2 |
| Pransky, SM | 3 |
| Albright, JT | 1 |
| Magit, AE | 3 |
| Chhetri, DK | 2 |
| Shapiro, NL | 2 |
| Neumann, K | 2 |
| Pudszuhn, A | 2 |
| Welzel, C | 2 |
| Bartel-Friedrich, S | 1 |
| Passmann, M | 1 |
| Naiman, AN | 3 |
| Ceruse, P | 1 |
| Peyton Shirley, W | 1 |
| Wiatrak, B | 1 |
| Kendall, KA | 1 |
| Schraff, S | 1 |
| Derkay, CS | 1 |
| Burke, B | 1 |
| Lawson, L | 1 |
| Mandell, DL | 1 |
| Arjmand, EM | 1 |
| Kay, DJ | 1 |
| Casselbrant, ML | 1 |
| Silverman, DA | 1 |
| Pitman, MJ | 1 |
| Co, J | 1 |
| Woo, P | 1 |
| Lee, AS | 1 |
| de Bilderling, G | 1 |
| Bodart, E | 1 |
| Tuerlinckx, D | 1 |
| Naesens, L | 2 |
| De Clercq, E | 4 |
| Snoeck, R | 4 |
| Cullen, RD | 1 |
| Zdanski, C | 1 |
| Palomar Asenjo, V | 1 |
| Palomar García, V | 1 |
| Soteras Ollé, J | 1 |
| Ruiz Giner, A | 1 |
| Shehab, N | 1 |
| Sweet, BV | 1 |
| Hogikyan, ND | 1 |
| Getz, AE | 1 |
| Scharf, J | 1 |
| Amin, MR | 1 |
| Huber, K | 1 |
| Sadick, H | 1 |
| Götte, K | 1 |
| Lee, JH | 2 |
| Inglis, AF | 1 |
| Wemer, RD | 1 |
| Tasca, RA | 1 |
| McCormick, M | 1 |
| Clarke, RW | 1 |
| Seymour, CW | 1 |
| Krimsky, WS | 1 |
| Sager, J | 1 |
| Kruklitis, RJ | 1 |
| Lund, ME | 1 |
| Musani, AI | 1 |
| Sterman, DH | 1 |
| Abedipour, D | 1 |
| Fresnel, E | 1 |
| Bour, JB | 1 |
| Pontes, P | 1 |
| Avelino, M | 1 |
| Pignatari, S | 1 |
| Weckx, LL | 1 |
| Shemen, LJ | 1 |
| Shnayder, Y | 1 |
| Sheahan, P | 1 |
| Sexton, S | 1 |
| Russell, JD | 1 |
| Chung, BJ | 1 |
| Giles, BL | 1 |
| Seifert, B | 1 |
| Nicollas, R | 1 |
| Landry, G | 1 |
| Colombeau, B | 1 |
| Bloching, M | 1 |
| James, AL | 1 |
| Bitar, M | 1 |
| Baz, R | 1 |
| Fuleihan, N | 1 |
| Muallem, M | 1 |
| Soma, MA | 1 |
| Albert, DM | 1 |
| Lindsay, F | 1 |
| Bloom, D | 1 |
| Pransky, S | 1 |
| Stabley, R | 1 |
| Shick, P | 1 |
| Shi, ZP | 1 |
| Wang, CH | 1 |
| Lee, JC | 1 |
| Lin, YS | 1 |
| Loyo, M | 1 |
| Pai, SI | 1 |
| Netto, GJ | 1 |
| Tunkel, DE | 1 |
| Broekema, FI | 1 |
| Tanna, N | 1 |
| Sidell, D | 1 |
| Joshi, AS | 1 |
| Bielamowicz, SA | 1 |
| Sutter, C | 1 |
| Greenhalgh, DA | 1 |
| Ueda, M | 1 |
| Abhyankar, S | 1 |
| Ngai, P | 1 |
| Hennings, H | 1 |
| Schweizer, J | 1 |
| Yuspa, SH | 1 |
| Strickland, JE | 1 |
| Peng, X | 1 |
| Lang, CM | 1 |
| Kreider, JW | 2 |
| Van Cutsem, E | 1 |
| Van Ranst, M | 2 |
| Fiten, P | 1 |
| Opdenakker, G | 1 |
| Geboes, K | 1 |
| Janssens, J | 1 |
| Rutgeerts, P | 1 |
| Vantrappen, G | 1 |
| Wellens, W | 2 |
| Desloovere, C | 1 |
| Feenstra, L | 2 |
| Petersen, BL | 1 |
| Buchwald, C | 1 |
| Gerstoft, J | 1 |
| Bretlau, P | 1 |
| Lindeberg, H | 1 |
| Kearns, DB | 2 |
| Kang, DR | 1 |
| Duncan, NO | 1 |
| Hashemiyoon, R | 1 |
| Hawrych, A | 1 |
| Brewster, DF | 1 |
| Dancey, DR | 1 |
| Chamberlain, DW | 1 |
| Krajden, M | 1 |
| Palefsky, J | 1 |
| Alberti, PW | 1 |
| Downey, GP | 1 |
| Christensen, ND | 1 |
| Pickel, MD | 1 |
| Budgeon, LR | 1 |
| Van Valckenborgh, I | 1 |
| De Boeck, K | 1 |
| Armbruster, C | 2 |
| Kreuzer, A | 1 |
| Vorbach, H | 1 |
| Huber, M | 1 |
| Auborn, KJ | 1 |
| Berke, GS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Use of Cidofovir Injection in the Treatment of Recurrent Respiratory Papillomatosis."[NCT00205374] | Phase 4 | 19 participants (Actual) | Interventional | 1999-11-30 | Completed | ||
| A Pilot Study to Evaluate the Effects of Antiangiogenic Factor as an Adjunct Treatment After Photoangiolysis in Patients With Bilateral Recurrent Respiratory Papillomatosis of the Vocal Fold[NCT01020747] | Phase 1 | 20 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Voice Handicap Index. This scale rates a patient's perception of voice related handicap in the domains of functional, physical, and emotional. There are 10 questions for each domain. Each question is rated by the subject on a 5-point scale, never =0, almost never =1, sometimes =2, almost always =3, always =4). A lower total score or domain score indicates improved, or less, voice handicap. Thus, the maximum total score is 4 X 30 = 120. For each domain, the maximum score is 4 X 10 = 40. Scores of 0 are the lowest possible score. In the paper we say that the Maximum score is 100, but obviously is it actually 120. Complete scale = 0-120.~Lower score indicates improved perceived voice-realted quality of life." (NCT00205374)
Timeframe: 2 months, and 12 months
| Intervention | scores on a scale (Mean) | |
|---|---|---|
| 2 months | 12 months | |
| Cidofovir | 22 | 31 |
| Placebo | 32 | 42 |
"Derkay Severity Score. Minimum Score is Zero. Maximum score is 86. Treatment of RRP with cidofovir injection will be considered efficacious if drug group patients experience clinically or statistically significant changes in papilloma severity and inter-surgery time intervals (relative to pre-treatment assessments), when compared with placebo group patients.~The scale rates - Voice (normal 0, abnormal 1, aphonic 2) Stridor (absent 0, present with activity 1, present at rest 2) Urgency of the intervention (scheduled 0, elective 1, urgent 2, emergent 3) Respiratory distress (none 0, mild 1, mod 2, severe 3, extreme 4).~For multiple anatomical sites (18 or more) in the upper airway, left and right sides, lesions are rated as 0=none, 1=surface lesion, 2=raised lesion, and 3=bulky lesion).~A higher rating value indicates more advanced disease and a worse outcome." (NCT00205374)
Timeframe: Baseline, 2 months, and 12 months
| Intervention | scores on a scale (Mean) | ||
|---|---|---|---|
| Baseline | 2 months | 12 months | |
| Cidofovir | 13.2 | 3.7 | 2.7 |
| Placebo | 12 | 3.6 | 5.1 |
Prior to each treatment,the area of reappearance of disease was measured and the % change from baseline was calculated. The change was then added to the % change from the previous treatment to generate a cumulative total % change of reappearance of RRP from baseline. The additive nature of this parameter resulted in % greater than 100% if the area of vocal fold affected by the RRP increased over the baseline measurement. (NCT01020747)
Timeframe: 6 months
| Intervention | total percentage change (Mean) |
|---|---|
| Bevacizumab Treated Vocal Fold | 85.3 |
| Untreated Vocal Fold | 225.3 |
15 reviews available for cytosine and Papilloma
| Article | Year |
|---|---|
Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Airway Obstruction; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; C | 2010 |
Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Airway Obstruction; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; C | 2012 |
Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir.
Topics: Antineoplastic Agents; Child, Preschool; Cidofovir; Cytosine; Female; Glottis; Humans; Injections, I | 2002 |
Current diagnostic and management trends for recurrent respiratory papillomatosis.
Topics: Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Humans; Neoplasm Recurrence, Local; Or | 2004 |
Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Topics: Adult; Antineoplastic Agents; Child; Cidofovir; Clinical Trials as Topic; Cytosine; Dose-Response Re | 2005 |
[Current therapeutic options for recurrent respiratory papillomatosis].
Topics: Adult; Chemotherapy, Adjuvant; Child; Cidofovir; Cytosine; Drug Combinations; Follow-Up Studies; Hum | 2005 |
Recurrent respiratory papillomatosis: pathogenesis to treatment.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Human papillomavirus 11; Human p | 2005 |
Transbronchial needle injection: a systematic review of a new diagnostic and therapeutic paradigm.
Topics: Bronchoscopy; Catheterization; Cidofovir; Cytosine; Equipment Design; Humans; Injections; Lung Disea | 2006 |
Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Neoplasm Recurrence, Local | 2007 |
Can zinc be an adjuvant therapy for juvenile onset recurrent respiratory papillomatosis?
Topics: Adolescent; Antiviral Agents; Chemotherapy, Adjuvant; Child, Preschool; Cidofovir; Cytosine; Drug Th | 2007 |
Cidofovir: to use or not to use?
Topics: Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Neo | 2008 |
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Child; Cidofovir; Cytosine; Female; Humans; Injec | 2008 |
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Neoplasm Recurrence, Local; Organophosphonates; Papil | 2008 |
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cystic Adenomatoid Malformation of Lung, Congenital; Cyt | 2000 |
Therapy for recurrent respiratory papillomatosis.
Topics: Cidofovir; Cytosine; Humans; Interferons; Laryngeal Neoplasms; Lung Neoplasms; Neoplasm Recurrence, | 2002 |
8 trials available for cytosine and Papilloma
| Article | Year |
|---|---|
Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cyto | 2008 |
Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort.
Topics: Antiviral Agents; Cidofovir; Cohort Studies; Cytosine; Drug Administration Schedule; Female; Humans; | 2002 |
A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
Topics: Antineoplastic Agents; Antineoplastic Protocols; Child; Child, Preschool; Cidofovir; Cytosine; Drug | 2003 |
Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Child, Preschool; Cidofovir; Cytosine; Debridement; F | 2004 |
3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Protocols; Child; Child, Preschool; Cidofovir; Cyt | 2006 |
Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; | 2006 |
Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report.
Topics: Adult; Antiviral Agents; Cidofovir; Clinical Protocols; Cytosine; Humans; Injections, Intralesional; | 2000 |
Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Injections, Intrales | 2000 |
59 other studies available for cytosine and Papilloma
| Article | Year |
|---|---|
Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Laryngeal Neopl | 2014 |
Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine model.
Topics: Animals; Bevacizumab; Biopsy, Needle; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Rel | 2017 |
Cidofovir modulated gene expression in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Down-Regulation; Gene Expression; Humans; Interferon Regulato | 2008 |
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient.
Topics: Administration, Topical; Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Cytosine; Endo | 2009 |
Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; | 2009 |
Use of cidofovir for treatment of recurrent respiratory papillomatosis.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papilloma; Recurrence; R | 2009 |
Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Databases, Factual; Fema | 2009 |
Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Cidofovir; Cytosine; Female; Follow-Up Studi | 2009 |
Treatment results in adult-onset recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuv | 2009 |
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cidofovir; Cytosine; Gene Expression Profiling; Gene Exp | 2009 |
Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis.
Topics: Adult; Antineoplastic Agents; Catheter Ablation; Cidofovir; Combined Modality Therapy; Cytosine; End | 2010 |
In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Humans; Injections, Intralesio | 2010 |
Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis.
Topics: Adolescent; Antineoplastic Agents; Chi-Square Distribution; Child; Child, Preschool; Cidofovir; Cyto | 2010 |
Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
Topics: Adult; Aged; Biopsy; Cidofovir; Cytosine; Disease Progression; Female; Follow-Up Studies; Humans; Ma | 2010 |
Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Laryngeal Neoplasms | 2010 |
Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Infusions, Intralesional; Organophosphonates; Papillo | 2010 |
Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
Topics: Antiviral Agents; Bronchoscopy; Cidofovir; Cytosine; Female; Humans; Injections, Intralesional; Lary | 2011 |
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intrales | 2012 |
Adjuvant therapy for laryngeal papillomatosis.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Antiviral Agents; Ch | 2011 |
Intralesional cidofovir in severe juvenile respiratory papillomatosis.
Topics: Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Dose-Response Relationship, Dru | 2012 |
Minimizing surgical management through the use of adjuvant medical therapies.
Topics: Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Cytosine; Humans; Laryngeal Neoplasms; O | 2012 |
Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections, | 2003 |
Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cy | 2003 |
Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.
Topics: Airway Obstruction; Antiviral Agents; Chemotherapy, Adjuvant; Child; Child, Preschool; Cidofovir; Co | 2003 |
[Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Topics: Adolescent; Adult; Aged; Airway Obstruction; Antiviral Agents; Chemotherapy, Adjuvant; Child; Child, | 2003 |
Intralesional cidofovir and surgical excision for laryngeal papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; | 2003 |
Current treatment for laryngeal papillomatosis.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modalit | 2004 |
American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
Topics: Antineoplastic Agents; Antiviral Agents; Australia; Chemotherapy, Adjuvant; Child; Child, Preschool; | 2004 |
Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
Topics: Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Debridement; Female; Humans; In | 2004 |
Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
Topics: Adult; Ambulatory Care; Antineoplastic Agents; Cidofovir; Cytosine; Female; Humans; Injections, Intr | 2004 |
Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Cidofovir; Cytosine; Female; Humans; Injectio | 2004 |
Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.
Topics: Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Cytosine; Drug Therapy, Combination; Fem | 2005 |
Delivery of cidofovir to respiratory papillomas of the distal trachea.
Topics: Antineoplastic Agents; Bronchoscopes; Child, Preschool; Cidofovir; Cytosine; Humans; Neoplasm Recurr | 2005 |
[Cidofovir activity in infantile recurrent respiratory papillomatosis].
Topics: Antiviral Agents; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Laryngea | 2005 |
Thyrohyoid approach to cidofovir injection: a case study.
Topics: Antineoplastic Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Laryngeal Neoplasms; | 2005 |
Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.
Topics: Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Humans; Injections, I | 2006 |
Cidofovir and the black box warning.
Topics: Animals; Antineoplastic Agents; Cidofovir; Cytosine; Disease Progression; Drug Labeling; Humans; Lar | 2005 |
Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis.
Topics: Adult; Antineoplastic Agents; Cidofovir; Cytosine; Disease Progression; Female; Humans; Injections, | 2005 |
British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
Topics: Anticarcinogenic Agents; Antiviral Agents; Child; Cidofovir; Cytosine; Databases, Factual; Health Ca | 2006 |
Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cytosine; DNA, Viral; Female; Follow-Up Studies; Human p | 2006 |
Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis.
Topics: Adult; Antineoplastic Agents; Cidofovir; Cytosine; Follow-Up Studies; Humans; Injections, Intralesio | 2006 |
Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study.
Topics: Adult; Antineoplastic Agents; Cidofovir; Cytosine; Follow-Up Studies; Humans; Injections, Intralesio | 2006 |
Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
Topics: Adjuvants, Pharmaceutic; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Comb | 2006 |
CR12/339--Nebulized cidofovir for recurrent respiratory papillomatosis: a case report.
Topics: Administration, Inhalation; Antineoplastic Agents; Cidofovir; Cytosine; Female; Follow-Up Studies; H | 2006 |
Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Topics: Adult; Aged; Antiviral Agents; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Fem | 2007 |
Histologic review of cidofovir-treated recurrent respiratory papillomatosis.
Topics: Antineoplastic Agents; Child; Cidofovir; Cytosine; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, | 2008 |
Cidofovir injection for recurrent laryngeal papillomatosis.
Topics: Adult; Antineoplastic Agents; Child; Cidofovir; Cytosine; Female; Humans; Injections; Laryngeal Neop | 2008 |
Aggressive recurrent respiratory papillomatosis in a neonate.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Cidofov | 2008 |
Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cidofovir; Cytosine; Female; Huma | 2008 |
SENCAR mouse skin tumors produced by promotion alone have A to G mutations in codon 61 of the c-rasHa gene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenine; Animals; Base Sequence; Cocarcinogenesis; Codon; Cytosine | 1994 |
Methylation of cottontail rabbit papillomavirus DNA and tissue-specific expression in transgenic rabbits.
Topics: 5-Methylcytosine; Animals; Animals, Genetically Modified; Cottontail rabbit papillomavirus; Cytosine | 1995 |
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Ne | 1995 |
Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Child; Cidofovir; Combined Modalit | 1998 |
An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract.
Topics: Adult; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; DNA, Viral; Fatal Outcome; | 1998 |
Intralesional cidofovir for recurrent respiratory papillomatosis in children.
Topics: Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections, Intrale | 1999 |
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, An | 2000 |
Systemic cidofovir in papillomatosis.
Topics: Antiviral Agents; Child; Cidofovir; Cytosine; Female; Humans; Neoplasm Invasiveness; Neoplasm Recurr | 2001 |
Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cidofovir; Cytosine; F | 2001 |
Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.
Topics: Adult; Ambulatory Care; Antineoplastic Agents; Cidofovir; Cytosine; Female; Follow-Up Studies; Human | 2002 |